A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor

Journal of Clinical Investigation

Volumn 102, Issue 7, 1998, Pages 1352-1359

  Beau, Isabelle ^a   Touraine, Philippe ^b   Meduri, Géri ^a   Gougeon, Alain ^c   Desroches, Agnès ^a   Matuchansky, Christine ^b   Milgrom, Edwin ^a   Kuttenn, Frédérique ^b   Misrahi, Micheline ^a  

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c INSERM   (France)

Author keywords

Follicle stimulating; Genetic; Hormone receptor; Infertility; Mutation; Premature ovarian failure

Indexed keywords

COMPLEMENTARY DNA; DNA; FOLLITROPIN; FOLLITROPIN RECEPTOR; IODINE 125;

ADULT; ARTICLE; CASE REPORT; FEMALE; FEMALE INFERTILITY; FINLAND; FOLLITROPIN BLOOD LEVEL; GENE MUTATION; HUMAN; OVARY DISEASE; OVARY FOLLICLE DEVELOPMENT; PHENOTYPE; PRIORITY JOURNAL;

EID: 0032190476     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3795     Document Type: Article

References (48)

1. Simoni, M., J. Gromoll, and E. Nieschlag. 1997. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr. Rev. 18:739-773.
2. Misrahi, M., M.T. Vu Hai, N. Ghinea, H. Loosfelt, G. Meduri, M. Atger, A. Jolivet, B. Gross, J.F. Savouret, P. Dessen, and E. Milgrom. 1993. Molecular and cellular biology of gonadotropin receptors. In The Ovary. E.Y. Adashi and C.K. Leung, editors. Raven Press, New York. 57-92.
3. Bick, D., B. Franco, R.J. Sherins, B. Heye, L. Pike, J. Crawford, A. Maddalena, B. Incerti, A. Pragliola, T. Meittinger, and A. Ballabio. 1992. Intragenic deletion of the KALIG-1 gene in Kallmann's syndrome. N. Engl. J. Med. 326: 1752-1755.
4. Hardelin, J.P., J. Levilliers, I. del Castillo, M. Cohen-Salmon, R. Legouis, S. Blanchard, S. Compain, P. Bouloux, J. Kirk, C. Moraine, et al. 1992. X-chromosome-linked Kallmann's syndrome: stop mutations validate the candidate gene. Proc. Natl. Acad. Sci. USA. 89:8190-8194.
5. de Roux, N., J. Young, M. Misrahi, R. Genet, P. Chanson, G. Schaison, and E. Milgrom. 1997. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N. Engl. J. Med. 337: 1597-1602.
6. Layman, L.C., D.P. Cohen, M. Jin, J. Xie, Z. Li, R.H. Reindollar, S. Bolbolan, D.P. Bick, R.R. Sherins, L.W. Duck, et al. 1998. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat. Genet. 18:14-15.
7. Matthews, C.H., S. Borgato, P. Beck-Peccoz, M. Adams, Y. Tone, G. Gambino, S. Casagrande, G. Tedeschini, A. Benedetti, and V.K.K. Chatterjee. 1993. Primary amenorrhea and infertility due to a mutation in the β subunit of follicle-stimulating hormone. Nat. Genet. 5:83-86.
8. Layman, L.C., E.J. Lee, D.B. Peajk, A.B. Nammmoum, K.V. Vu, B.L. Van Lingen, M.R. Gray, P.G. McDonough, R.H. Reindollar, and J.L. Jameson. 1997. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone β-subunit gene. N. Engl. J. Med. 337:607-611.
9. Weiss, J., L. Axelrod, R.W. Whittcomb, P.E. Harris, W.F. Crowley, and J.L. Jameson. 1992. Hypogonadism caused by a single amino acid substitution in the β subunit of luteinizing hormone. N. Engl. J. Med. 326:1799-1803.
10. Kremer, H., R. Kraaij, S.P.A. Toledo, M. Post, J.B. Fridman, C.Y. Van Reen, E. Milgrom, H.H. Ropers, E. Mariman, A.P.N. Themmen, and H.G. Brunner. 1995. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat. Genet. 9:160-164.
11. Laue, L.L., S.M. Wu, M. Kudo, A.J.W. Hsueh, G.B. Cutler, Jr., J.E. Griffin, J.D. Wilson, C. Brain, A.C. Berry, D.B. Grant, and W.Y. Chan. 1995. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum. Mol. Genet. 4:1429-1433.
12. Latronico, A.C., J. Anasti, I.J. Arnhold, R. Rapaport, B.B. Mendonca, W. Castro, C. Tsigos, and G.P. Chrousos. 1996. Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N. Engl. J. Med. 334:507-512.
13. Laue, L.L., S.M. Wu, M. Kudo, C.J. Bourdony, G.B. Cutler, Jr., A.J.W. Hsueh, and W. Y. Chan. 1996. Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol. Endocrinol. 10: 987-997.
14. Misrahi, M., G. Meduri, S. Pissard, C. Bouvattier, I. Beau, H. Loosfelt, A. Jolivet, E. Milgrom, and P. Bougnères. 1997. Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J. Clin. Endocrinol. Metab. 82:2159-2165.
15. Toledo, S.P.A., H.G. Brunner, R. Kraaij, M. Post, P.L.M. Dahia, C.Y. Hayashida, H. Kremer, and A.P.N. Themmen. 1996. An inactivating mutation of the LH receptor causes amenorrhea in a 46 XX female. J. Clin. Endocrinol. Metab. 81:3850-3854.
16. Aittomäki, K., J.L.D. Lucena, P. Pakarinen, P. Sistonen, J. Tapanainen, J. Gromoll, R. Kaskikari, E.M. Sankila, H. Lehväslaiho, A.R. Engel, et al. 1995. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 82:959-968.
17. Aittomäki, K., R. Herva, U.H. Stenman, K. Juntunen, P. Ylöstalo, O. Hovatta, and A. de la Chapelle. 1996. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J. Clin. Endocrinol. Metab. 81:3722-3726.
18. Conway, E., W. Höppner, J. Gromoll, M. Simoni, and G.S. Conway. 1997. Mutations of the FSH receptor gene are rare in familial and sporadic premature ovarian failure. J. Endocrinol. 152(Suppl.):P257.
19. Groome, N.P., P.J. Illingworth, M. O'Brien, R. Pai, F.E. Rodger, J.P. Mather, and A.S. McNeilly. 1996. Measurement of dimeric inhibin B throughout the human menstrual cycle. J. Clin. Endocrinol. Metab. 81:1401-1405.
20. Kanis, J.A., and the WHO Study Group. 1994. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporosis Int. 4:368-381.
21. Bergh, C., C.M. Howles, K. Borg, L. Hamberger, B. Josefsson, L. Nilsson, and M. Wikland. 1997. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum. Reprod. 12:2133-2139.
22. Gromoll, J., E. Pekel, and E. Nieschlag. 1996. The structure and organization of the human follicle-stimulating hormone receptor gene. Genomics. 35: 308-311.
23. Vannier, B., H. Loosfelt, G. Meduri, C. Pichon, and E. Milgrom. 1996. Anti-human FSH receptor monoclonal antibodies: immunochemical and immunocytochemical characterization of the receptor. Biochemistry. 35:1359-1366.
24. Beau, I., M. Misrahi, B. Gross, B. Vannier, H. Loosfelt, M.T. Vu Hai, C. Pichon, and E. Milgrom. 1997. Basolateral localization and transcytosis of gonadotropin and thyrotropin receptors expressed in MDCK cells. J. Biol. Chem. 272: 5241-5248.
25. de Roux, N., M. Misrahi, R. Brauner, M. Houang, J.C. Carel, M. Granier, Y. Le Bouc, N. Ghinea, A. Boumedienne, J.E. Toublanc, and E. Milgrom. 1996. Four families with loss of function mutations of the TSH receptor. J. Clin. Endocrinol. Metab. 81:4229-4235.
26. Le Bivic, A., Y. Sambuy, A. Patzak, N. Patil, M. Chao, and E. Rodriguez-Boulan. 1991. An internal deletion in the cytoplasmic tail reverses the apical localization of human NGF receptor in transfected MDCK cells. J. Cell Biol. 115:607-618.
27. Meduri, G., N. Charnaux, H. Loosfelt, A. Jolivet, F. Sypratos, S. Brailly, and E. Milgrom. 1997. LH/hCG receptors in breast cancer. Cancer Res. 57:857-864.
28. Meduri, G., M.T. Vu Hai, A. Jolivet, S. Takemori, S. Kominami, M.A. Driancourt, and E. Milgrom. 1996. Comparison of cellular distribution of LH receptors and steroidogenic enzymes in the porcine ovary. J. Endocrinol. 148: 435-446.
29. Dupont, E., V. Luu The, F. Labrie, and G. Pelletier. 1990. Light microscopic immunocytochemical localization of 3β-hydroxy-5-ene-steroid dehydrogenase/Δ5-Δ4 isomerase in the gonads and adrenal glands of the guinea pig. Endocrinology. 126:2906-2909.
30. Kominami, S., K. Shinzawa, and S. Takemori. 1983. Immunochemical studies on cytochrome P450 in adrenal microsomes. Biochim. Biophys. Acta. 755:163-169.
31. Kitawaki, J., N. Yoshida, and Y. Osawa. 1989. An enzyme-linked immunosorbent assay for quantitation of aromatase cytochrome P-450. Endocrinology. 124:1417-1423.
32. Inkster, S.E., and A.M.H. Brodie. 1991. Expression of aromatase cytochrome P-450 in premenopausal and postmenopausal human ovaries: an immunocytochemical study. J. Clin. Endocrinol. Metab. 73:717-726.
33. Tamura, T., J. Kitawaki, T. Yamamoto, Y. Osawa, S. Kominamis, S. Takemaris, and H. Okadah. 1992. Immunohistochemical localization of 17 α-hydroxylase/C17-20 lyase and aromatase cytochrome P450 in the human ovary during the menstrual cycle. J. Endocrinol. 135:589-595.
34. Gougeon, A. 1996. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr. Rev. 17:121-155.
35. Hillier, S.G. 1994. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum. Reprod. 9:188-191.
36. Segaloff, D.L., and M. Ascoli. 1993. The lutropin/choriogonadotropin receptor 4 years later. Endocr. Rev. 14:324-347.
37. Themmen, A.P.N., and H.G. Brunner. 1996. Luteinizing hormone receptor mutations and sex differentiation. Eur. J. Endocrinol. 134:533-540.
38. Misrahi, M., and E. Milgrom. 1997. The TSH receptor. In Pharmacotherapeutics of the Thyroid Gland. A.P. Weetman and A. Grossman, editors. Springer-Verlag, Berlin/Heidelberg/New York. 128:33-73.
39. Abramowicz, M.J., L. Duprez, J. Parma, G. Vassart, and C. Heinrichs. 1997. Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J. Clin. Invest. 99:3018-3024.
40. Rozell, T.G., H. Wang, X. Liu, and D.L. Segaloff. 1995. Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not the lutropin/choriogonadotropin receptor. Mol. Endocrinol. 9:1727-1736.
41. Gromoll, J., M. Simoni, and E. Nieschlag. 1996. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermato-genesis in a hypophysectomized man. J. Clin. Endocrinol. Metab. 81:1367-1370.
42. Kumar, T.R., Y. Wang, L. Naifang, and M.M. Matzuk. 1997. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat. Genet. 15:201-204.
43. McNatty, K.P., A. Makris, C. De Grazia, R. Osathanondh, and K.J. Ryan. 1980. Steroidogenesis by recombined follicular cells from the human ovary in vitro. J. Clin. Endocrinol. Metab. 51:1286-1292.
44. Menon, V., R. Logan Edwards, W.R. Butt, M. Bluck, and S.S. Lynch. 1984. Review of 59 patients with hypergonadotrophic amenorrhea. Br. J. Obstet. Gynaecol. 91:63-66.
45. Conway, G.S. 1997. Premature ovarian failure. Curr. Opin. Obstet. Gynecol. 9:202-206.
46. Starup, J., V. Sele, and B. Henriksen. 1971. Amenorrhoea associated with increased production of gonadotrophins and a morphologically normal ovarian follicular apparatus. Acta Endocrinol. 66:248-256.
47. Mehta, A.E., I. Matwijiw, E.A. Lyons, and C. Faiman. 1992. Noninvasive diagnosis of resistant ovary syndrome by ultrasonography. Fertil. Steril. 57: 56-61.
48. Shangold, M.M., R.N. Turksoy, R.A. Bashford, and C.B. Hammond. 1977. Pregnancy following the "insensitive ovary syndrome." Fertil. Steril. 28: 1179-1181.